In the late 1800s, William B. Coley used crude bacterial extracts to treat tumor patients. He found that the extracts were effective in inducing tumor necrosis. However, patients treated with his extracts were also found to suffer from a severe systematic inflammatory reaction. One of the major factors in stimulating such inflammatory reactions in humans is now known as tumor necrosis factor alpha (TNFα).